Showing results (211-220 of 693) with videos related to
Sort By:
Pageof 70
Revue Medicale De Liege|November 21, 2002
[Clinical study of the month. The MRC/BHF Heart Protection Study]H Kulbertus, A J ScheenRevue Medicale De Liege|April 8, 2017
[About the choice between a DPP-4 inhibitor and a SGLT 2 inhibitor tor treating type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|April 8, 2017
[Optimizing basal insulin therapy in type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|July 19, 2003
[Statins for cardiovascular prevention: is there still a place for cholesterol measurement?]A J Scheen, H KulbertusRevue Medicale De Liege|March 8, 2021
[Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?]A J Scheen, N PaquotRevue Medicale De Liege|February 26, 2014
[European guidelines for the management of diabetes, prediabetes and cardiovascular disease. Second part. Managemnet of cardiac, cerebrovascular and peripheral artery complications]A J Scheen, P LancellottiRevue Medicale De Liege|July 23, 2005
[Prevention of type 2 diabetes: a new public health challenge]A J Scheen, D GietRevue Medicale De Liege|January 14, 2005
[Interheart: nine risk factors predict nine out of ten myocardial infarctions]A J Scheen, H KulbertusRevue Medicale De Liege|April 12, 2005
[PPAR-gamma receptors, new therapeutic target in metabolic and cardiovascular diseases]A J Scheen, N PaquotDiabetes & Metabolism|September 30, 2018
Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular diseaseF Bonnet, A J ScheenPageof 70